Moreover, the recruitment of independent oncogenic signaling pathways through FLT3ITD/NFATC1 cooperativity might explain, why oncogenic driver mutations such as FLT3ITD—though being instrumental for AML initiation—become dispensable for AML maintenance, once NFATC1 is overexpressed. Here, NFATC1 is linked to acute myeloid leukemia.